KEYTRUDA

Product NDC
0006-3026
11-digit product format
000063026
Labeler code
0006
Product ID
0006-3026_2251fde0-831a-4f47-a325-0859f3a235e7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
pembrolizumab
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
Merck Sharp & Dohme LLC
Application
BLA125514
Marketing category
BLA
Marketing start
2015-01-15
Substance
PEMBROLIZUMAB
Active strength
25 mg/mL
Pharmacologic classes
Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
KEYTRUDA
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
PEMBROLIZUMAB25 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiDPT0O3T46P
Rxcui1657746, 1657749, 1657750, 1657751

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
8e8f9c11-8c94-4615-8579-57b2877ce51bProduct name120150325
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0006-3026-01KEYTRUDA4 mL in 1 VIALINJECTION, SOLUTION4225
0006-3026-02KEYTRUDA1 in 1 CARTONINJECTION, SOLUTION1225
0006-3026-04KEYTRUDA2 in 1 CARTONINJECTION, SOLUTION2225

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0006-3026-01ML - Milliliter0006-3026d8761ae6-588d-4951-a8a1-d69c1e45739c12015-02-02
0006-3026-02ML - Milliliter0006-302666905acf-023d-4924-8e6a-51c55601066a12015-02-02
0006-3026-04ML - Milliliter0006-3026022b47ae-26ce-484a-97be-aced4f144fe812019-09-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
pembrolizumabACTIVE INGREDIENTDPT0O3T46PKEYTRUDA (PEMBROLIZUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION KEYTRUDA (PEMBROLIZUMAB) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]9
pembrolizumabACTIVE MOIETYDPT0O3T46PKEYTRUDA (PEMBROLIZUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION KEYTRUDA (PEMBROLIZUMAB) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]9
HISTIDINEINACTIVE INGREDIENT4QD397987EKEYTRUDA (PEMBROLIZUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION KEYTRUDA (PEMBROLIZUMAB) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]9
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBKEYTRUDA (PEMBROLIZUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION KEYTRUDA (PEMBROLIZUMAB) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]9
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HKEYTRUDA (PEMBROLIZUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION KEYTRUDA (PEMBROLIZUMAB) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]9
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IKEYTRUDA (PEMBROLIZUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION KEYTRUDA (PEMBROLIZUMAB) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]9
SUCROSEINACTIVE INGREDIENTC151H8M554KEYTRUDA (PEMBROLIZUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION KEYTRUDA (PEMBROLIZUMAB) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]9
WATERINACTIVE INGREDIENT059QF0KO0RKEYTRUDA (PEMBROLIZUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION KEYTRUDA (PEMBROLIZUMAB) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.]9

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0006-3026KEYTRUDA (PEMBROLIZUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION KEYTRUDA (PEMBROLIZUMAB) INJECTION, SOLUTION [MERCK SHARP & DOHME LLC ]207Current NDC, Legacy NDC, 3 package rows20250430_9333c79b-d487-4538-a9f0-71b91a02b287.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1657751Keytruda 100 MG in 4 ML InjectionPSN9333c79b-d487-4538-a9f0-71b91a02b287225
1657749Keytruda 50 MG InjectionPSN9333c79b-d487-4538-a9f0-71b91a02b287225
1657750pembrolizumab 100 MG in 4 ML InjectionPSN9333c79b-d487-4538-a9f0-71b91a02b287225
1657746pembrolizumab 50 MG InjectionPSN9333c79b-d487-4538-a9f0-71b91a02b287225
16577514 ML pembrolizumab 25 MG/ML Injection [Keytruda]SBD9333c79b-d487-4538-a9f0-71b91a02b287225
1657749pembrolizumab 50 MG Injection [Keytruda]SBD9333c79b-d487-4538-a9f0-71b91a02b287225
16577504 ML pembrolizumab 25 MG/ML InjectionSCD9333c79b-d487-4538-a9f0-71b91a02b287225
1657746pembrolizumab 50 MG InjectionSCD9333c79b-d487-4538-a9f0-71b91a02b287225
1657751Keytruda 100 MG per 4 ML InjectionSY9333c79b-d487-4538-a9f0-71b91a02b287225
1657749Keytruda 50 MG InjectionSY9333c79b-d487-4538-a9f0-71b91a02b287225
1657750pembrolizumab 100 MG per 4 ML InjectionSY9333c79b-d487-4538-a9f0-71b91a02b287225

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0006-3026-01000063026014 mL in 1 VIAL4 mlHistorical
0006-3026-02000063026021 VIAL in 1 CARTON (0006-3026-02) / 4 mL in 1 VIAL (0006-3026-01) 1 vial2015-01-150000-00-00NoNoCurrent
0006-3026-04000063026042 VIAL in 1 CARTON (0006-3026-04) / 4 mL in 1 VIAL (0006-3026-01) 2 vial2019-08-010000-00-00NoNoCurrent